Covid-19 challenges to immune investigations and therapies

Int Immunopharmacol. 2021 Jun:95:107543. doi: 10.1016/j.intimp.2021.107543. Epub 2021 Feb 27.

Authors

James E Talmadge¹, Francois Marceau²

Affiliations

¹ Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA. Electronic address: jtalmadg@unmc.edu.
² Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1V 4G2, Canada. Electronic address: francois.marceau@crchudequebec.ulaval.ca.

No abstract available

Publication types

Editorial

MeSH terms

COVID-19 / etiology
COVID-19 / immunology*
COVID-19 / therapy*
COVID-19 Vaccines / immunology
COVID-19 Vaccines / therapeutic use
Humans
Immunomodulation
SARS-CoV-2 / immunology*
SARS-CoV-2 / pathogenicity

Substances

COVID-19 Vaccines